NASDAQ:DXCM - DexCom Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $120.95 -3.13 (-2.52 %) (As of 03/26/2019 04:00 PM ET)Previous Close$124.08Today's Range$120.14 - $125.6052-Week Range$69.51 - $156.16Volume1.45 million shsAverage Volume1.40 million shsMarket Capitalization$10.89 billionP/E Ratio403.17Dividend YieldN/ABeta0.78 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings DexCom (NASDAQ:DXCM) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.18 Wall Street analysts have issued ratings and price targets for DexCom in the last 12 months. Their average twelve-month price target is $149.5333, suggesting that the stock has a possible upside of 23.63%. The high price target for DXCM is $175.00 and the low price target for DXCM is $125.00. There are currently 6 hold ratings and 12 buy ratings for the stock, resulting in a consensus rating of "Buy."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: BuyBuyBuyBuyConsensus Rating Score: 2.672.682.652.64Ratings Breakdown: 0 Sell Rating(s)6 Hold Rating(s)12 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)6 Hold Rating(s)13 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)7 Hold Rating(s)13 Buy Rating(s)0 Strong Buy Rating(s)1 Sell Rating(s)6 Hold Rating(s)15 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $149.5333$147.8667$132.6471$111.6389Price Target Upside: 23.63% upside1.11% upside3.72% upside23.99% downsideDexCom (NASDAQ:DXCM) Consensus Price Target History DexCom (NASDAQ:DXCM) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails2/25/2019Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$135.00 ➝ $160.00Low2/22/2019CowenBoost Price TargetOutperform$150.00 ➝ $175.00High2/22/2019Canaccord GenuityBoost Price TargetBuy$140.00 ➝ $160.00High1/9/2019Piper Jaffray CompaniesBoost Price TargetAverage ➝ Overweight$165.00High1/8/2019UBS GroupBoost Price TargetNeutral ➝ Neutral$135.00 ➝ $140.00Medium12/6/2018OppenheimerSet Price TargetBuy$150.00Medium11/7/2018Jefferies Financial GroupBoost Price TargetBuy$148.00Low11/7/2018StephensBoost Price TargetOverweight$170.00 ➝ $160.00Low10/23/2018Raymond JamesBoost Price TargetOutperform ➝ Outperform$125.00 ➝ $150.00Low10/19/2018Goldman Sachs GroupUpgradeSell ➝ Neutral$125.00High9/12/2018Northland SecuritiesUpgradeUnder Perform ➝ Market PerformHigh8/23/2018Robert W. BairdBoost Price TargetOutperform ➝ Positive$140.00 ➝ $160.00Low8/15/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$127.00 ➝ $145.00High8/6/2018Berenberg BankUpgradeHold ➝ Buy$140.00Low8/2/2018BMO Capital MarketsBoost Price TargetOutperformer ➝ Outperform$112.00 ➝ $125.00High8/2/2018JPMorgan Chase & Co.Boost Price TargetOverweight$140.00High5/3/2018BTIG ResearchReiterated RatingHoldHigh4/3/2018GuggenheimInitiated CoverageNeutral ➝ NeutralHigh3/4/2018Northcoast ResearchReiterated RatingBuyHigh1/8/2018BarclaysReiterated RatingHold$60.00High10/4/2017WedbushReiterated RatingBuy$76.00Low9/29/2017Leerink SwannReiterated RatingBuy$85.00 ➝ $57.00High9/28/2017CitigroupDowngradeOutperform ➝ Market PerformHigh5/7/2017B. RileyReiterated RatingBuy$95.00High4/27/2017William BlairReiterated RatingOutperformLow4/4/2017Royal Bank of CanadaReiterated RatingOutperform$87.00Medium(Data available from 3/26/2017 forward) This page was last updated on 3/26/2019 by MarketBeat.com StaffFeatured Article: What is the return on assets formula?